Pretoria, 23 May 2026 – The South African Health Products Regulatory Authority (SAHPRA), in collaboration with the South African Pharmacy Council (SAPC), has intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and GIP medicines containing either Semaglutide, Tirzepatide, or a combination...
The South African Health Product Regulatory Authority (SAHPRA) Complementary Medicines’ (CMs’) Hybrid Workshop successfully took place, offering attendees the option to participate either in person or via a virtual platform. Key areas discussed during the workshop included: SAHPRA responded to the 21 questions regarding Complementary Medicines...
Pretoria, 10 October 2023 –The South African Health Products Regulatory Authority (SAHPRA) participated in a Carte Blanche media interview on an ongoing investigation into the illicit bulk sale of codeine-based cough mixtures. This investigative report was broadcast on Sunday, 08 October 2023. The report relates to...
SAHPRA hosted a Live Webinar: Codeine-Containing Medicines – Unpacking the Dangers of Irresponsible Behaviour and Abuse. Recording below: ...
19 July 2021 As South Africa’s statutory health regulatory bodies, the South African Health Products Regulatory Authority (SAHPRA), Health Professions Council of South Africa (HPCSA), Office of Health Standards Compliance (OHSC), South African Nursing Council (SANC) and South African Pharmacy Council (SAPC) together with the National...
